UP!

News

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-03-01 Future report Set alerts
Q3 2020 2020-11-05 Future report Set alerts
Q2 2020 2020-08-06 -0.41 -0.41
Q1 2020 2020-04-30 -0.70 -0.70
Q4 2019 2020-02-27 -0.86 -0.86
Q3 2019 2019-11-07 -0.72 -0.72
Q2 2019 2019-08-01 -0.78 -0.78
Q1 2019 2019-05-02 -0.93 -0.93
Q4 2018 2019-02-28 -0.89 -0.89
Q3 2018 2018-11-01 -0.74 -0.74

Ratings

2016-07-11 Reiterated Rating Brean Capital Buy
2016-07-01 Initiated Coverage Stifel Nicolaus Buy $23.00
2016-05-24 Reiterated Rating Brean Capital Buy
2016-05-06 Reiterated Rating Brean Capital Buy $25.00
2016-04-30 Reiterated Rating Brean Capital Buy
2016-03-09 Lower Price Target JMP Securities Market Outperform $28.00 to $24.00
2016-03-09 Lower Price Target JPMorgan Chase & Co. Market Outperform $28.00 to $24.00
2016-03-05 Reiterated Rating Brean Capital Buy
2016-01-26 Reiterated Rating Aegis Buy
2015-11-08 Reiterated Rating Brean Capital Buy $25.00
2015-10-19 Reiterated Rating Aegis Buy $26.00 to $31.00
2015-10-09 Boost Price Target JMP Securities $28.00
2015-10-08 Initiated Coverage Roth Capital Buy $32.00
2015-10-08 Reiterated Rating Brean Capital Buy
2015-09-23 Reiterated Rating Aegis Buy $26.00
2015-09-23 Reiterated Rating Brean Capital Buy $21.00 to $25.00
2015-09-22 Reiterated Rating Roth Capital Buy $22.00 to $32.00
2015-09-14 Reiterated Rating Brean Capital Buy $21.00
2015-09-09 Initiated Coverage Aegis Buy $26.00
2015-08-12 Initiated Coverage Brean Capital Buy $21.00
2015-06-24 Boost Price Target Ladenburg Thalmann Buy $24.00 to $27.00
2015-05-20 Reiterated Rating Roth Capital Buy $22.00
2015-05-12 Reiterated Rating Roth Capital Buy $19.00 to $22.00
2015-04-01 Set Price Target Roth Capital Buy $19.00
2014-11-12 Reiterated ROTH Capital Buy $28 to $21
2014-11-12 Lower Price Target Roth Capital Buy $28.00 to $21.00
2014-07-08 Reiterated Rating Roth Capital Buy
2014-06-26 Initiated Coverage Ladenburg Thalmann Buy $24.00
2014-05-29 Initiated Coverage Roth Capital Buy $28.00
2014-03-19 Initiated Coverage Roth Capital Buy $28.00
2014-03-10 Initiated Coverage Wells Fargo & Co. Outperform
2014-03-10 Initiated Coverage JMP Securities Outperform
2014-03-10 Initiated Coverage Wells Fargo Outperform
2016-07-11 Reiterated Rating Brean Capital Buy
2016-07-01 Initiated Coverage Stifel Nicolaus Buy $23.00
2016-05-24 Reiterated Rating Brean Capital Buy
2016-05-06 Reiterated Rating Brean Capital Buy $25.00
2016-04-30 Reiterated Rating Brean Capital Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
BROOKSIDE CAPITAL MANAGEMENT LLC 8.31%  (1497833) CNCE / DRNA / IDIX / NSPH / RDUS /
GLAXOSMITHKLINE PLC Former 10% Owner 7.52%  (1356533) AGTC / CNCE / FOLD / GNCA / OMED / PATH / TBPH / THRX /
Freund John Gordon 6.70%  (1208920) CNCE / MAKO / PRTO / TTPH / XNPT /
Skyline Venture Partners Qualified Purchaser Fund IV L P 6.70%  (1208920) ABIO / ACRX / CNCE / TTPH /
Flagship Ventures Fund 2004 L P 3.64%  (656490) BIND / CNCE / TTOO / TTPH /
Tung Roger D Chief Executive Officer 3.32%  (598923) CNCE /
QVT Associates GP LLC 3.11%  (559999) ACHN / AGEN / CNCE / TKMR /
Adage Capital Partners, L.P. 2.83%  (510147) CNCE /
TVM Life Science Ventures VI GmbH & Co KG 2.10%  (378703) CNCE / OPXA / PRTO /
BVF PARTNERS L P/IL 0.68%  (122496) ARQL / ARRY / CAPS / CCXI / CNCE / CTIC / INFI / LGND / NBIX / ONTY / PTN / RGDO / RGEN / RIGL / TRGT / XENE /
Stuart Nancy Chief Operating Officer 0.67%  (121376) CNCE /
New Leaf Ventures I, L.P. 0.60%  (107327) CNCE / RLYP / TSPT /
Greylock XII GP LLC 0.37%  (67256) APTI / CNCE / RDFN /
Silverman Robert Senior VP, General Counsel 0.23%  (40912) CNCE /
HERSCHA LYNETTE General Counsel 0.19%  (33818) CNCE /
Cassella James V Chief Development Officer 0.17%  (30000) ALXA / CNCE /
THREE ARCH MANAGEMENT III LLC 0.16%  (29052) ACRX / CNCE /
Three Arch Management IV, L.L.C. 0.07%  (12301) ACRX / CNCE /
Lynch Ryan PFO, PAO 0.03%  (5039) CNCE /
HUTT PETER BARTON 0.02%  (4424) BIND / CNCE / IMMU / MNTA / XOMA /
Auchincloss Thomas G 0.01%  (2000) CNCE /

Comments